Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “DENALI THERAPEUTICS INC.”

41 pharma patents match "DENALI THERAPEUTICS INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 41
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 41 pharmaceutical patents matching "DENALI THERAPEUTICS INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

41 results for “DENALI THERAPEUTICS INC.” · 30,257 patents in full index Clear search

  1. US 12378540

    Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof

    DENALI THERAPEUTICS INC. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  2. US 12358928

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  3. US 12358896

    LRRK2 inhibitors and methods of making and using thereof

    DENALI THERAPEUTICS INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  4. US 12240902

    Anti-TREM2 antibodies and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted
  5. US 12180211

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  6. US 12162948

    Methods of engineering transferrin receptor binding polypeptides

    DENALI THERAPEUTICS INC. · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  7. US 12129263

    Kinase inhibitors and uses thereof

    DENALI THERAPEUTICS INC. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  8. US 11999750

    Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide

    DENALI THERAPEUTICS INC. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  9. US 11958840

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  10. US 11912778

    Methods of engineering transferrin receptor binding polypeptides

    DENALI THERAPEUTICS INC. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  11. US 11884944

    Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof

    DENALI THERAPEUTICS INC. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  12. US 11866742

    Fusion proteins comprising enzyme replacement therapy enzymes

    DENALI THERAPEUTICS INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  13. US 11851440

    Modulators of eukaryotic initiation factor 2B, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  14. US 11851433

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  15. US 11834439

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  16. US 11795232

    Engineered transferrin receptor binding polypeptides

    DENALI THERAPEUTICS INC. · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  17. US 11773185

    Anti-BACE1 antibodies and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted
  18. US 11661461

    Phospho-Rab antibodies, assays and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted May 30, 2023 · Expires May 25, 2043

    granted
  19. US 11643446

    Progranulin variants

    DENALI THERAPEUTICS INC. · Granted May 9, 2023 · Expires May 4, 2043

    granted
  20. US 11591316

    Compounds, compositions, and methods

    DENALI THERAPEUTICS INC. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  21. US 11427571

    Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

    DENALI THERAPEUTICS INC. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted
  22. US 11370832

    Anti-Tau antibodies and methods of use thereof

    DENALI THERAPEUTICS INC. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  23. US 11306077

    Compounds, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted
  24. US 11236100

    Modulators of eukaryotic initiation factor 2B, compositions and methods

    DENALI THERAPEUTICS INC. · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted